PATENT CLAIM ANALYSIS

Application Number: 15914717
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "085200"]

Abstract:
Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith, are provided.

Claim (Index 76):
A method of treating a solid tumor in a human subject, comprising:\n administering to the human subject a therapeutically effective amount of a PEG-IL-10 agent sufficient to maintain an IL-10 serum trough concentration of the PEG-IL-10 agent in the human subject at or above 1 ng/ml over a period of time of at least one week; wherein said administering treats the solid tumor in the human subject.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14779929', '15543949', '15513825', '14908992', '15313465']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7284542495167199
- 35 USC 102 Novelty (BERT): 0.527162614047423
- Combined Prediction Score: 0.7083250859697902
- Mean Citation Score: 332.470534
- Max Citation Score: 359.40314
- Similarity Product: 351.1116747090197

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test